Breast cancer genomic test could spare millions from chemotherapy
BY THE OPTIMIST DAILY EDITORIAL TEAM For decades, high clinical risk and chemotherapy arrived together as a package deal in early breast cancer. A trial presented at the American Society of Clinical Oncology meeting in Chicago on May 30, 2026, is pulling them apart. The OPTIMA trial enrolled Read More...
A daily pill just doubled survival time for advanced pancreatic cancer
BY THE OPTIMIST DAILY EDITORIAL TEAM In a 500-patient trial at American Society of Clinical Oncology's (ASCO) annual meeting in Chicago, a daily pill called daraxonrasib doubled average survival time in patients with advanced pancreatic cancer. Those on the drug lived for an average of 13.2 Read More...